Microstructural Damage to the Optic Nerve with Vigabatrin Treatment in West Syndrome: A DTI Study

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objective: This study aimed to assess the side effects of vigabatrin (VGB), focusing on optic nerve fiber damage in children with West syndrome, using DTI imaging parameters. Method: Clinical data and DTI images were analyzed, recording FA and ADC values for both optic nerves. ROC curves were used to determine fractional anisotropy thresholds for optic nerve damage. Results: Thirty-five children with West syndrome (0.3-22 months old, male: female = 19:16) were divided into three groups: (1) VGB and other anti-seizure medications (ASMs) with symmetrical thalamus abnormalities, (2) VGB and ASMs without thalamus abnormalities, and (3) control group with other ASMs. FA values in group 1 were significantly lower than in group 3 (P < 0.05), and FA values increased after VGB discontinuation (P < 0.05). The ROC analysis showed a cut-off score of 304 with 63.6% sensitivity and 100% specificity for detecting optic nerve damage. Conclusion: FA values are effective imaging markers for detecting VGB-induced optic nerve damage in West syndrome, especially when thalamus abnormalities are present. FA values significantly improve after stopping VGB treatment.

Article activity feed